Skip to main content

People with type 1 diabetes held back from sport due to stigma and fear of hypos

Our survey has shown that half of people with type 1 diabetes feel that the condition holds them back from physical activity and exercise.
27 September 2023

Close up of someone kneeling down and tying the shoelace on their trainer whilst on a running track

Our survey has shown that half of people with type 1 diabetes feel that the condition holds them back from physical activity and exercise.

Stigma and lack of support

Almost half of those surveyed had experienced stigmatising comments about type 1 and exercise. 46% of respondents had been told – incorrectly – that they were inactive or lazy because of their type 1. 48% had been told that people with type 1 aren’t able to be physically active, which is also incorrect.

Only 6% of respondents had regularly found sports coaches, PE teachers and gym instructors to be educated about type 1 diabetes and physical activity.

Hypos and complexity of type 1

Fear of hypos (low blood glucose levels which can cause unconsciousness or even be fatal) was reported by 46% of respondents as the main reason for not engaging in physical activity. This was despite an overall satisfaction (71%) with how they manage their blood glucose levels.

Respondents also reported that fluctuations in their glucose levels often made them feel too unwell to exercise or that having to stop exercise to managing glucose levels was too frustrating and put them off.

People with type 1 want to exercise – just like anybody else

Although exercise can help stabilise blood glucose levels, the majority of respondents wanted to do exercise for reasons unrelated to their type 1 diabetes. Over two-thirds of people surveyed wanted to do physical activity for the benefit of their general and mental health, to have fun and feel good.

Exercise and physical activity can have varying effects on blood glucose levels and it affects everyone with type 1 differently. In general, gentle exercise like walking can cause blood glucose to drop, whereas high energy or endurance exercise can cause blood glucose to rise, due to spikes in adrenaline.

Physical activity isn’t just sport

Physical activity isn’t limited to just sports and exercise sessions. 47% people of people surveyed cited housework as one of their weekly physical activities, 29% shopping, and 6% DIY and 5% gardening.

The report calls for more information and support for people with type 1 who want to take part in physical activity, and for more education for people running sports and exercise activities.

What do these findings mean for people with type 1?

Chris Bright, JDRF’s Community Partnerships and Events Lead, who led the project, said:

“What the survey shows us is that people with type 1 diabetes want to do exercise for the same reasons anyone else does – though we know it can also be beneficial for blood glucose management. However, there are clearly barriers in place that prevent people with type 1 from doing the exercise they want to do; from stigma and misconceptions about type 1 to concerns about the impact that exercise will have on blood glucose levels. What’s needed is more support for people with type 1 and education for people running sports and exercise activities.”

How we’re working for change

JDRF UK has already begun work to improve knowledge and education around type 1 and exercise, working in partnership with The Football Association of Wales, The Diabetes Football Community and Diabetes UK to produce guidance for football coaches on type 1 diabetes. As well as providing information and support online and through their Community Engagement Team, JDRF run regular events on managing type 1 and exercise, both in-person and virtually. JDRF’s Community Engagement team also work with partners in the healthcare profession, such as EXTOD.

Chris said:

“Empowering people with information is key, as is working in partnerships with sporting organisations and groups. We have the evidence, what we are doing now is working to make change happen on the ground.”

We would like to thank the Trustees of the Peter Harrison Foundation for their generous support which made this vital work possible.

You may also be interested in

Read more
Two women dressed in sportswear sitting on a park bench after exercising

Exercise and type 1 diabetes

Whether you’re walking the dog, ballet dancing or training for a marathon, learn how to manage your glucose levels and insulin intake for exercising.

Read more
A person with type 1 diabetes doing a finger prick test to check their blood glucose levels

Managing type 1 diabetes

Our guide to managing type 1 diabetes gives you information and support on how to manage your blood glucose levels, count carbs and deal with hypos and hypers.

Read more

Type 1 information events

Our free events offer a great opportunity to meet others with type 1 diabetes. Hear from leading experts, explore type 1 tech and take part in discussions groups on a wide variety of topics.

Related news

Read more
Nina Willer, who used hybrid closed loop technology through pregnancy, and her child.
Treatment research
7 November 2023

Hybrid closed loop technology set to be made available in England and Wales

The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.

Read more
T cell immune system
6 November 2023

New research highlights the effectiveness of immune therapies for type 1 diabetes

The research, which was co-funded by JDRF, reveals that drugs that target the immune system offer very effective and rapid improvements in stabilising blood sugar levels, often within just three months.

Read more
Dr Ify Mordi, lead type 1 diabetes researcher
Clinical trials
25 October 2023

JDRF award £1.5 million grant to University of Dundee for type 1 diabetes clinical trial

The new JDRF-funded clinical trial called SOPHIST will test a drug to help people with type 1 diabetes and heart failure.

Read more
Young person receiving an injection of the immunotherapy drug teplizumab.jpg
18 October 2023

Clinical trial finds teplizumab slows type 1 diabetes in people newly diagnosed 

Results from a clinical trial called the PROTECT study show that teplizumab can preserve beta cell function in children and adolescents newly diagnosed with type 1 diabetes.

Connect with us on social